Vaccine-Associated Herpes Zoster

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 10
Volume 6
Issue 10

A 23-month-old girl presented with an erythematous papular rash on her torso that extended in a linear pattern around to the back. The mother first noticed the rash while bathing the child 3 days earlier. The child had no associated itching, irritability, or fever, but she had mild rhinorrhea preceding the rash that resolved without treatment. The patient and her older sibling were cared for at home by their mother.

A 23-month-old girl presented with an erythematous papular rash on her torso that extended in a linear pattern around to the back. The mother first noticed the rash while bathing the child 3 days earlier. The child had no associated itching, irritability, or fever, but she had mild rhinorrhea preceding the rash that resolved without treatment. The patient and her older sibling were cared for at home by their mother.

The toddler was afebrile and appeared relatively happy. Based on the patient's clinical presentation and history, which included varicella vaccination at 12 months of age, a diagnosis of post-vaccination herpes zoster was made.

According to the CDC, post-vaccination herpes zoster develops in about 18 of 100,000 children. Because varicella is a live vaccine, the virus may lie dormant in the CNS and become activated at any time; however, reactivation is usually secondary to a depressed immune system.

This infant was treated with a 5-day course of acyclovir. The family was cautioned to keep the rash covered because of the slight risk of spreading the virus through contact with open vesicles. *

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Related Content
© 2025 MJH Life Sciences

All rights reserved.